Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation

Journal of Cell Science

Volumn 118, Issue 14, 2005, Pages 3173-3183

  He, Yaowu ^a   Brown, Melissa A ^a   Rothnagel, Joseph A ^a   Saunders, Nicholas A ^a   Smith, Ross ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

BRCA1; Cell cycle dependence; hnRNP; p21; p53

Indexed keywords

BRCA1 PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1; ISOPROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL CYCLE PHASE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENES, BRCA1; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; RNA, HETEROGENEOUS NUCLEAR; RNA, MESSENGER; TRANSFECTION;

EID: 23844489788     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02448     Document Type: Article

References (63)

1. Ben-David, Y., Bani, M. R., Chabot, B., De Koven, A. and Bernstein, A. (1992). Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth. Mol. Cell Biol. 12, 4449-4455.
2. Biamonti, G., Bassi, M. T., Cartegni, L., Mechta, F., Buvoli, M., Cobianchi, F. and Riva, S. (1993). Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter. J. Mol. Biol. 230, 77-89.
3. Brockstedt, E., Rickers, A., Kostka, S., Laubersheimer, A., Dorken, B., Wittmann-Liebold, B., Bommert, K. and Otto, A. (1998). Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J. Biol. Chem. 273, 28057-28064.
4. Brummelkamp, T. R., Bernards, R. and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553.
5. Buvoli, M., Biamonti, G., Tsoulfas, P., Bassi, M. T., Ghetti, A., Riva, S. and Morandi, C. (1988). cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. Nucleic Acids Res. 16, 3751-3770.
6. Celis, J. E., Bravo, R., Arenstorf, H. P. and LeStourgeon, W. M. (1986). Identification of proliferation-sensitive human proteins amongst components of the 40 S hnRNP particles. Identity of hnRNP core proteins in the HeLa protein catalogue. FEBS Lett. 194, 101-109.
7. Clemens, M. J., Trayner, I. and Menaya, J. (1992). The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J. Cell Sci. 103, 881-887.
8. Dallaire, F., Dupuis, S., Fiset, S. and Chabot, B. (2000). Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro. J. Biol. Chem. 275, 14509-14516.
9. Dreyfuss, G., Matunis, M. J., Pinol-Roma, S. and Burd, C. G. (1993). hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62, 289-321.
10. Dreyfuss, G., Kim, V. N. and Kataoka, N. (2002). Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3, 195-205.
11. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
12. Erlitzki, R. and Fry, M. (1997). Sequence-specific binding protein of single-stranded and unimolecular quadruplex telomeric DNA from rat hepatocytes. J. Biol. Chem. 272, 15881-15890.
13. Fielding, P., Turnbull, L., Prime, W., Walshaw, M. and Field, J. K. (1999). Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin. Cancer Res. 5, 4048-4052.
14. Fishman, D. D., Segal, S. and Livneh, E. (1998). The role of protein kinase C in G1 and G2/M phases of the cell cycle (review). Int. J. Oncol. 12, 181-186.
15. Good, P. J., Rebbert, M. L. and Dawid, I. B. (1993). Three new members of the RNP protein family in Xenopus. Nucleic Acids Res. 21, 999-1006.
16. Goto, Y., Sueoka, E., Chiba, H. and Fujiki, H. (1999). Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jpn. J. Cancer Res. 90, 1358-1363.
17. Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F. et al. (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
18. Hamasaki, M., Kamma, H., Wu, W., Kaneko, S., Fujiwara, M., Satoh, H., Haraoka, S., Kikuchi, M. and Shirakusa, T. (2001). Expression of hnRNP B1 in four major histological types of lung cancers. Anticancer Res. 21, 979-984.
19. Hermann, R., Hensel, F., Muller, E. C., Keppler, M., Souto-Carneiro, M., Brandlein, S., Muller-Hermelink, H. K. and Vollmers, H. P. (2001). Deactivation of regulatory proteins hnRNP A1 and A2 during SC-1 induced apoptosis. Hum. Antibodies 10, 83-90.
20. Hoek, K. S., Kidd, G. J., Carson, J. H. and Smith, R. (1998). hnRNP A2 selectively binds the cytoplasmic transport sequence of myelin basic protein mRNA. Biochemistry 37, 7021-7029.
21. Kamma, H., Horiguchi, H., Wan, L., Matsui, M., Fujiwara, M., Fujimoto, M., Yazawa, T. and Dreyfuss, G. (1999). Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. Exp. Cell Res. 246, 399-411.
22. Kamma, H., Satoh, H., Matusi, M., Wu, W. W., Fujiwara, M. and Horiguchi, H. (2001). Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle. Immunol. Lett. 76, 49-54.
23. Kelman, Z. (1997). PCNA: structure, functions and interactions. Oncogene 14, 629-640.
24. Krecic, A. M. and Swanson, M. S. (1999). hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11, 363-371.
25. LaBranche, H., Dupuis, S., Ben-David, Y., Bani, M. R., Wellinger, R. J. and Chabot, B. (1998). Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat. Genet. 19, 199-202.
26. Leser, G. P. and Martin, T. E. (1987). Changes in heterogeneous nuclear RNP core polypeptide complements during the cell cycle. J. Cell Biol. 105, 2083-2094.
27. LeStourgeon, W. M. B. A., Christensen, M. E., Walker, B. W., Poupore, S. M. and Daniels, L. P. (1978). The packaging proteins of core hnRNP particles and the maintenance of proliferative cell states. Cold Spring Harb. Symp. Quant. Biol. 42, 885-898.
28. Loeb, J. E., Ritz, E., Creuzet, C. and Jami, J. (1976). Comparison of chromosomal proteins of mouse primitive teratocarcinoma, liver and L cells. Exp. Cell Res. 103, 450-453.
29. Ma, A. S., Moran-Jones, K., Shan, J., Munro, T. P., Snee, M. J., Hoek, K. S. and Smith, R. (2002). Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein. J. Biol. Chem. 277, 18010-18020.
30. Martin, T., Jones, R. and Billings, P. (1979). HnRNP core proteins: synthesis, turnover and intracellular distribution. Mol. Biol. Rep. 5, 37-42.
31. Minoo, P., Sullivan, W., Solomon, L. R., Martin, T. E., Toft, D. O. and Scott, R. E. (1989). Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins. J. Cell Biol. 109, 1937-1946.
32. Montuenga, L. M., Zhou, J., Avis, I., Vos, M., Martinez, A., Cuttitta, F., Treston, A. M., Sunday, M. and Mulshine, J. L. (1998). Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am. J. Respir. Cell Mol. Biol. 19, 554-562.
33. Mulshine, J. L., Cuttitta, F., Tockman, M. S. and De Luca, L. M. (2002). Lung cancer evolution to preinvasive management. Clin. Chest Med. 23, 37-48.
34. Pan, Z. Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A. and Hurwitz, J. (1995). Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J. Biol. Chem. 270, 22008-22016.
35. Patry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Wellinger, R. and Chabot, B. (2003). Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res. 63, 7679-7688.
36. Percipalle, P., Jonsson, A., Nashchekin, D., Karlsson, C., Bergman, T., Guialis, A. and Daneholt, B. (2002). Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins. Nucleic Acids Res. 30, 1725-1734.
37. Perez-Roger, I., Kim, S. H., Griffiths, B., Sewing, A. and Land, H. (1999). Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18, 5310-5320.
38. Pino, I., Pio, R., Toledo, G., Zabalegui, N., Vicent, S., Rey, N., Lozano, M. D., Torre, W., Garcia-Foncillas, J. and Montuenga, L. M. (2003). Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 41, 131-143.
39. Rappsilber, J., Ryder, U., Lamond, A. I. and Mann, M. (2002). Large-scale proteomic analysis of the human spliceosome. Genome Res. 12, 1231-1245.
40. Rosenberger, U., Lehmann, I., Weise, C., Franke, P., Hucho, F. and Buchner, K. (2002). Identification of PSF as a protein kinase Calpha-binding protein in the cell nucleus. J. Cell Biochem. 86, 394-402.
41. Schwantke, N., Le Bouffant, F., Doree, M. and Le Peuch, C. J. (1985). Protein kinase C: properties and possible role in cellular division and differentiation. Biochimie 67, 1103-1110.
42. Shyu, A. B. and Wilkinson, M. F. (2000). The double lives of shuttling mRNA binding proteins. Cell 102, 135-138.
43. Somasundaram, K., Zhang, H., Zeng, Y. X., Houvras, Y., Peng, Y., Wu, G. S., Licht, J. D., Weber, B. L. and El-Deiry, W. S. (1997). Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389, 187-190.
44. Sourvinos, G. and Spandidos, D. A. (1998). Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Commun. 245, 75-80.
45. Sueoka, E., Goto, Y., Sueoka, N., Kai, Y., Kozu, T. and Fujiki, H. (1999). Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res. 59, 1404-1407.
46. Sueoka, E., Sueoka, N., Goto, Y., Matsuyama, S., Nishimura, H., Sato, M., Fujimura, S., Chiba, H. and Fujiki, H. (2001). Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res. 61, 1896-1902.
47. Tani, H., Ohshima, K., Haraoka, S., Hamasaki, M., Kamma, H., Ikeda, S. and Kikuchi, M. (2002). Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin. Int. J. Oncol. 21, 957-963.
48. Thiede, B., Dimmler, C., Siejak, F. and Rudel, T. (2001). Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J. Biol. Chem. 276, 26044-26050.
49. Thiede, B., Siejak, F., Dimmler, C. and Rudel, T. (2002). Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis. Proteomics 2, 996-1006.
50. Tockman, M. S., Mulshine, J. L., Piantadosi, S., Erozan, Y. S., Gupta, P. K., Ruckdeschel, J. C., Taylor, P. R., Zhukov, T., Zhou, W. H., Qiao, Y. L. et al. (1997). Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res. 3, 2237-2246.
51. Ullrich, S. J., Anderson, C. W., Mercer, W. E. and Appella, E. (1992). The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem. 267, 15259-15262.
52. Vermeulen, K., Van Bockstaele, D. R. and Berneman, Z. N. (2003). The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36, 131-149.
53. Waga, S., Li, R. and Stillman, B. (1997). p53-induced p21 controls DNA replication. Leukemia 11 Suppl. 3, 321-323.
54. Watters, D. J. and Parsons, P. G. (1999). Critical targets of protein kinase C in differentiation of tumour cells. Biochem. Pharmacol. 58, 383-388.
55. Weighardt, F., Biamonti, G. and Riva, S. (1996). The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. BioEssays 18, 747-756.
56. Whitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O. et al. (2002). Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977-2000.
57. Wu, S., Sato, M., Endo, C., Sakurada, A., Dong, B., Aikawa, H., Chen, Y., Okada, Y., Matsumura, Y., Sueoka, E. et al. (2003). hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 41, 179-186.
58. Xu, X., Joh, H. D., Pin, S., Schiller, N. I., Prange, C., Burger, P. C. and Schiller, M. R. (2001). Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype. Cancer Lett. 171, 67-77.
59. Yan-Sanders, Y., Hammons, G. J. and Lyn-Cook, B. D. (2002). Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett. 183, 215-220.
60. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B. and Mercer, W. E. (1995). p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55, 668-674.
61. Zhou, J., Mulshine, J. L., Unsworth, E. J., Scott, F. M., Avis, I. M., Vos, M. D. and Treston, A. M. (1996). Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J. Biol. Chem. 271, 10760-10766.
62. Zhou, J., Allred, D. C., Avis, I., Martinez, A., Vos, M. D., Smith, L., Treston, A. M. and Mulshine, J. L. (2001a). Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res. Treat. 66, 217-224.
63. Zhou, J., Nong, L., Wloch, M., Cantor, A., Mulshine, J. L. and Tockman, M. S. (2001b). Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer 34, 341-350.